Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples